H. Ralph Snodgrass, PRES./CHIEF SCIENTIFIC OFFICER at VistaGen Therapeutics, Inc. (VTGN), bought 3,750 shares at $2.73 ($10K) on 2021-08-17, disclosed to the SEC on 2021-08-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.